DermAI: Clinical dermatology acquisition through quality-driven image collection for AI classification in mobile

AI-based dermatology adoption remains limited by biased datasets, variable image quality, and limited validation. We introduce DermAI, a lightweight, smartphone-based application that enables real-time capture, annotation, and classification of skin lesions during routine consultations. Unlike prior dermoscopy-focused tools, DermAI performs on-device quality checks, and local model adaptation. The DermAI clinical dataset, encompasses a wide range of skin tones, ethinicity and source devices. In preliminary experiments, models trained on public datasets failed to generalize to our samples, while fine-tuning with local data improved performance. These results highlight the importance of standardized, diverse data collection aligned with healthcare needs and oriented to machine learning development.

An analysis of data variation and bias in image-based dermatological datasets for machine learning classification

AI algorithms have become valuable in aiding professionals in healthcare. The increasing confidence obtained by these models is helpful in critical decision demands. In clinical dermatology, classification models can detect malignant lesions on patients' skin using only RGB images as input. However, most learning-based methods employ data acquired from dermoscopic datasets on training, which are large and validated by a gold standard. Clinical models aim to deal with classification on users' smartphone cameras that do not contain the corresponding resolution provided by dermoscopy. Also, clinical applications bring new challenges. It can contain captures from uncontrolled environments, skin tone variations, viewpoint changes, noises in data and labels, and unbalanced classes. A possible alternative would be to use transfer learning to deal with the clinical images. However, as the number of samples is low, it can cause degradations on the model's performance; the source distribution used in training differs from the test set. This work aims to evaluate the gap between dermoscopic and clinical samples and understand how the dataset variations impact training. It assesses the main differences between distributions that disturb the model's prediction. Finally, from experiments on different architectures, we argue how to combine the data from divergent distributions, decreasing the impact on the model's final accuracy.